Stay updated with breaking news from Kyle Lahucik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Join Novo Nordisk, Scientific American, The Cancer Research Institute, Sofinnova, Members of the Media and More Than 1,300 Investors Helping to Drive Biotech Innovation, Digital Medicine and Global Collaboration at Biotech Showcase™Registration and Partnering Platform Access Now AvailableSAN FRANCISCO--(BUSINESS WIR...
The rise of new products in California doesn’t bode well for the FDA’s forthcoming rule, set to be finalized later this year.
Pfizer picks from Roche's executive team, snagging pharma early R&D leader William Pao as the Big Pharma's next chief development officer. Leo Pharma poaches from ... a Danish meme stock for its new CEO, who will lead a reorganization of the dermatology biopharma. And Sio Gene Therapies CEO Cheruvu is out the door as Parkinson's program also hits the exit.
Former FDA head Stephen Hahn is adding a new title to his role at Flagship Pioneering: CEO of the incubator's blood cancer test startup Harbinger Health. Takeda's oncology leader Rachael Brake heads to Corbus as chief scientific officer charged with redefining scope of early-stage pipeline. Goldfinch Bio snags 13-year Ardelyx vet as CSO.
GlaxoSmithKline poached Pfizer's RNA and viral vaccines leader Phil Dormitzer, M.D., Ph.D., to shore up its vaccine business as it's lost many research staffers this past year. Parthenon Therapeutics snagged Johnson & Johnson's global head of cell therapy platform and discovery, Tamas Oravecz, Ph.D. And Rafael parted ways with five execs and reinstalled telecom tycoon Howard Jonas as CEO.